Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The role of Tumor Necrosis Factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus

Full text
Author(s):
Postal, Mariana [1] ; Appenzeller, Simone [1]
Total Authors: 2
Affiliation:
[1] Univ Estadual Campinas, Fac Med Sci, Rheumatol Unit, Dept Med, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 1
Document type: Review article
Source: CYTOKINE; v. 56, n. 3, p. 537-543, DEC 2011.
Web of Science Citations: 67
Abstract

The Tumor Necrosis Factor-alpha (TNF-alpha) is a pleiotropic cytokine that produces different stimuli in various physiological and pathological conditions. TNF-alpha contributes importantly to the development of T cells, B cells, and dendritic cells. However, TNF-alpha is also a potent inflammatory mediator and apoptosis inducer. The significance of the TNF-alpha involvement in the pathogenesis of systemic lupus erythematosus (SLE) remains controversial. From the genetic standpoint, a number of studies suggest that the TNF-alpha gene polymorphism is involved in the susceptibility of SLE. Moreover, there is a close association between the TNF-alpha gene expression and clinical manifestations. In addition, the increased serum level of TNF-alpha is observed in SLE patients and associated with disease activity and certain systemic manifestations. Treatment with anti-TNF agents is, however, controversial in SLE since induction of antinuclear antibodies, anti-dsDNA, anticardiolipin antibodies, and cases of drug-induced lupus have been observed in rheumatoid arthritis patients. In this context, this study reviewed the importance of TNF-alpha in the pathogenesis of SLE. (C) 2011 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 09/06049-6 - Blood and cerebrospinal fluid biomarkers associated with structural and functional central nervous system abnormalities in Systemic lupus erythematosus
Grantee:Simone Appenzeller
Support Opportunities: Scholarships in Brazil - Young Researchers
FAPESP's process: 08/02917-0 - Blood and cerebrospinal fluid biomarkers associated with structural and functional central nervous system abnormalities in systemic lupus erythematosus
Grantee:Simone Appenzeller
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 09/11076-2 - Levels of interferon alpha, gamma and TNF alpha in patients of SLE: association with clinical manifestations
Grantee:Mariana Postal Zink de Souza
Support Opportunities: Scholarships in Brazil - Master